Benoît Pinteur (Chief Scientific Officer, PharmD) brings 25 years of experience in the pharma industry with roles at Shering-Plough and Roche, mainly in pharmaceutical development.
From previous collaboration with international teams on autologous cancer immunotherapy, he decided to create Brenus Pharma to address previous limitations of cancer vaccines.
Benoit was formerly the CEO of BioElpida, a CDMO where he developed expertise in ATMP and GMP manufacturing with a special focus on immunotherapies, cell therapies and vaccines.
Current role
Co-Founder & Chief Scientific Officer at Sprint Bioscience
Co-founder & Chief Scientific Officer at Apellis Pharmaceuticals
Founder & Chief Scientific Officer At Vitract at Vitract
Founder, Chief Scientific Officer & Director at Inhalon
Co-founder, Chief Scientific Officer at ElectricFish
Access the worlds's biggest network of public org charts
Learn more